Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

11.93
Delayed Data
As of Aug 07
 -0.22 / -1.81%
Today’s Change
6.07
Today|||52-Week Range
13.76
+21.73%
Year-to-Date
Harmony Biosciences Starts U.S. IPO Effort
Jul 31 / Seeking Alpha - Paid Partner Content
Teva announces filing of Ajovy application in Japan
Jul 29 / Seeking Alpha - Paid Partner Content
Craving Healthcare: A Beginner's Guide And My 7 Picks
Jul 31 / Seeking Alpha - Paid Partner Content
 

Today’s Trading

Previous close12.15
Today’s open12.11
Day’s range11.82 - 12.12
Volume6,185,128
Average volume (3 months)11,638,503
Market cap$13.1B
Data as of 4:00pm ET, 08/07/2020

Growth & Valuation

Earnings growth (last year)+60.78%
Earnings growth (this year)+4.53%
Earnings growth (next 5 years)+3.63%
Revenue growth (last year)-9.92%
P/E ratio1,192.0
Price/Sales0.63
Price/Book0.93

Competitors

 Today’s
change
Today’s
% change
BGNEBeigene Ltd-3.45-1.54%
BBIOBridgeBio Pharma Inc+0.53+1.90%
--Immunotech Laborator...0.000.00%
Data as of 3:59pm ET, 08/07/2020

Financials

Next reporting dateOctober 29, 2020
EPS forecast (this quarter)$0.58
Annual revenue (last year)$16.9B
Annual profit (last year)-$1.0B
Net profit margin-5.92%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
No executives to display
Corporate headquarters
Petach Tikva, Hamerkaz

Forecasts